Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA three lines addition to consent documents cost $3 per trial participant

This article was originally published in Scrip

Executive Summary

When US Congress passed the Drug Administration Amendments Act of 2007 (FDAAA) that, amongst other measures, introduced the publicly accessible database of clinical trials (www.ClinicalTrials.gov), it may not have realised how complicated it would be to introduce wording into informed consent document telling trial subjects that results of their trials would be included on that website.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC011367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel